Methyl-n-amylnitrosamine

Methyl-n-amylnitrosamine (MNAN) is a potential carcinogen[1] It is metabolized in the liver by the enzyme CYP2A6.

Methyl-n-amylnitrosamine
Names
Preferred IUPAC name
N-Methyl-N-pentylnitrous amide
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
MeSH N-amyl-N-methylnitrosamine
Properties
C6H14N2O
Molar mass 130.191 g·mol−1
Appearance Yellow, transparent liquid
log P 1.542
Related compounds
Related amines
Related compounds
Agmatine
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YN ?)
Infobox references

References

  1. Bulay O, Mirvish SS (September 1979). "Carcinogenesis in rat esophagus by intraperitoneal injection of different doses of methyl-n-amylnitrosamine". Cancer Res. 39 (9): 3644–6. PMID 476689.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.